GeoWealth Management »

Mineralys Therapeutics shares owned by GeoWealth Management

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by GeoWealth Management from 13F filings

Historical chart of GeoWealth Management investment in Mineralys Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 2917.5k17.6k17.7k14381,438.514391,439.51440
Value ($)Share countHistorical MLYS position of GeoWealth Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by GeoWealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by GeoWealth Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $18k 1.4k 12.31
2024-09-30 $17k 1.4k 12.11

More positions owned by GeoWealth Management

Ishares Tr Core Total Usd (IUSB)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Dimensional Etf Trust World Ex Us Core (DFAX)
Ishares Tr Core Intl Aggr (IAGG)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Exchange Listed Fds Tr Cabana Target 10 (TDSC)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Dimensional Etf Trust Natl Mun Bd Etf (DFNM)
Exchange Listed Fds Tr Cabana Moderate (CLSM)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)

View all positions for GeoWealth Management

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
Sr One Capital Management
Franklin Resources
OrbiMed Advisors
Vanguard Group
Laurion Capital Management
Adams Street Partners
Millennium Management
Jennison Associates
Caligan Partners
Integral Health Asset Management

View all funds holding Mineralys Therapeutics